Singota Solutions (Bloomington, Indiana CDMO) discusses Mitigating Risk: Safeguarding Commercialization Timelines with Shipping Validation. Singota specializes in injectable drug development, formulation development, aseptic filling, and supply chain management.
Sitav Elturan Best Practices, Industry, Supply Chain Management, Testing

Mitigating Risk: Safeguarding Commercialization Timelines with Shipping Validation

Advancing therapeutics from early development into commercial readiness requires an understanding of how products behave not only in controlled laboratory environments, but throughout the logistical pathways they navigate. While formulation, manufacturing, and stability evaluations are established components of development programs, the conditions encountered during transportation can introduce additional mechanical and…
Read More
Singota Solutions (Bloomington, Indiana CDMO) discusses Factors In Developing Injectable Drug Placebo Formulations For Pharmaceutical Clinical Trials. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Sitav Elturan Best Practices, Manufacturing, Testing

Factors in Developing Injectable Drug Placebo Formulations for Pharmaceutical Clinical Trials

In the dynamic landscape of pharmaceutical research, the significance of placebo-controlled trials as a litmus test for evaluating the efficacy of emerging medications cannot be overstated. However, the efficacy of such trials hinges upon a meticulous understanding and implementation of placebo development practices. This article from Singota Solutions (Bloomington, Indiana…
Read More
Singota Solutions Aseptic Filling CDMO in Bloomington, Indiana, discusses Analysis Paralysis: Navigating Early-Phase Analytical Validation. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Jacob Wheeler Best Practices, Development, Quality Assurance, Testing

Analysis Paralysis: Navigating Early-Phase Analytical Validation

Significant confusion persists across the pharmaceutical/biopharmaceutical industry relevant to early-phase analytical development and analytical validation. While several guidance documents serve as a de facto standard, distinguishing method validation requirements from suggestions, when and how to apply those guidelines often is not a straightforward task.It is critical to establish a product/project’s…
Read More
CDMO Singota Solutions (Bloomington, Indiana) discusses Which Testing Does An Effective Certificate Of Analysis Include? Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Site Admin Best Practices, Quality Assurance, Testing

Which Testing Does An Effective Certificate Of Analysis Include?

Source: Singota Solutions By Ken Chomistek, Singota Solutions Compendial monograph (pharmacopeial) testing applied to pharmaceutical raw materials and finished drug products is a critical element of drug development. A testing record is created in the form of a Certificate of Analysis (CoA) for manufacturing release and distribution. However, the testing required…
Read More